{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:56:25Z","timestamp":1792842985354,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252292"],"award-info":[{"award-number":["7252292"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22278449"],"award-info":[{"award-number":["22278449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272111"],"award-info":[{"award-number":["82272111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92159303"],"award-info":[{"award-number":["92159303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20731"],"award-info":[{"award-number":["U24A20731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114189","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:23:05Z","timestamp":1757254985000},"page":"114189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immunomodulatory microbubbles targeting integrin \u03b1v\u03b23 in combination with immunotherapy for the theranostic of anaplastic thyroid cancer in mice"],"prefix":"10.1016","volume":"387","author":[{"given":"Wang","family":"Liangkai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Jiaojiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xinyao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Jiajia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xuejiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xinyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Taulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114189_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer: American Thyroid Association anaplastic thyroid cancer guidelines task force","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.jconrel.2025.114189_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101678","article-title":"Anaplastic thyroid cancer: an update","volume":"37","author":"Rao","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2025.114189_bb0015","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Filetti","year":"2019","journal-title":"Anal. Oncol."},{"key":"10.1016\/j.jconrel.2025.114189_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-018-0903-0","article-title":"Therapeutic advances in anaplastic thyroid cancer: a current perspective","volume":"17","author":"Saini","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114189_bb0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","article-title":"Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study","volume":"33","author":"Subbiah","year":"2022","journal-title":"Anal. Oncol."},{"key":"10.1016\/j.jconrel.2025.114189_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173712","article-title":"A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer","volume":"9","author":"Han","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2025.114189_bb0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1089\/thy.2020.0322","article-title":"Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma","volume":"31","author":"Dierks","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.jconrel.2025.114189_bb0040","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114189_bb0045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.114189_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114189_bb0055","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/onc.2011.395","article-title":"Development of a listeria monocytogenes-based vaccine against hepatocellular carcinoma","volume":"31","author":"Chen","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2025.114189_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","article-title":"Tumor microenvironment: barrier or opportunity towards effective cancer therapy","volume":"29","author":"Tiwari","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2025.114189_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cells9010046","article-title":"Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses","volume":"9","author":"Anfray","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.114189_bb0070","doi-asserted-by":"crossref","first-page":"eabl3649","DOI":"10.1126\/scitranslmed.abl3649","article-title":"Albumin nanoparticle containing a PI3K\u03b3 inhibitor and paclitaxel in combination with \u03b1-PD1 induces tumor remission of breast cancer in mice","volume":"14","author":"Song","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114189_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00262-024-03779-2","article-title":"Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature","volume":"73","author":"Xu","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2025.114189_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302013","article-title":"Size-tunable Nanoregulator-based radiofrequency ablation suppresses MDSCs and their compensatory immune evasion in hepatocellular carcinoma","volume":"12","author":"Tang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114189_bb0085","article-title":"Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment","volume":"12","author":"O\u2019Connell","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114189_bb0090","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1158\/1078-0432.CCR-22-3313","article-title":"Eganelisib, a first-in-class PI3K\u03b3 inhibitor, in patients with advanced solid tumors: results of the phase 1\/1b MARIO-1 trial","volume":"29","author":"Hong","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114189_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2020.06.008","article-title":"Ultrasound and microbubble mediated therapeutic delivery: underlying mechanisms and future outlook","volume":"326","author":"Chowdhury","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114189_bb0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2174\/0929867327666200212100257","article-title":"Applications of Micro\/nanotechnology in ultrasound-based drug delivery and therapy for tumor","volume":"28","author":"Sun","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114189_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111623","article-title":"Integrin \u03b1v\u03b23-targeted liposomal drug delivery system for enhanced lung cancer therapy","volume":"201","author":"Fu","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.114189_bb0110","doi-asserted-by":"crossref","first-page":"eadg7125","DOI":"10.1126\/sciadv.adg7125","article-title":"TERT accelerates BRAF mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis","volume":"9","author":"Yu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114189_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12022-024-09832-1","article-title":"Unravelling the reasons behind limited response to anti-PD therapy in ATC: a comprehensive evaluation of tumor-infiltrating immune cells and checkpoints","volume":"35","author":"Boruah","year":"2024","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.jconrel.2025.114189_bb0120","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1021\/acsnano.3c01019","article-title":"Janus silica nanoparticle-based tumor microenvironment modulator for restoring tumor sensitivity to programmed cell death ligand 1 immune checkpoint blockade therapy","volume":"17","author":"Lin","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114189_bb0125","first-page":"557","article-title":"Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy","volume":"17","author":"Wang","year":"2022","journal-title":"Asian J. Pharm Sci."},{"key":"10.1016\/j.jconrel.2025.114189_bb0130","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/s41467-022-30543-w","article-title":"Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis","volume":"13","author":"Guan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114189_bb0135","article-title":"Engineering ROS-responsive bioscaffolds for disrupting myeloid cell-driven immunosuppressive niche to enhance PD-L1 blockade-based postablative immunotherapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114189_bb0140","doi-asserted-by":"crossref","first-page":"1900037","DOI":"10.1002\/advs.201900037","article-title":"Multifunctional nanoregulator reshapes immune microenvironment and enhances immune memory for tumor immunotherapy","volume":"6","author":"Yu","year":"2019","journal-title":"Adv. Sci. (Weinh)."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114189_bb0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41416-022-02076-y","article-title":"Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect","volume":"128","author":"Liu","year":"2023","journal-title":"Br. J. Cancer."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:09:31Z","timestamp":1780477771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"alternative-id":["S0168365925008016"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114189","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory microbubbles targeting integrin \u03b1v\u03b23 in combination with immunotherapy for the theranostic of anaplastic thyroid cancer in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114189"}}